Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.12% |
| 2 | Technology | 7.86% |
| 3 | Healthcare | 6.8% |
| 4 | Industrials | 5.01% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
10x Genomics
TXG
$6.61B
| $6.09M | ﹤0.01% |
213,907
+146,891
| +219% | +$5.6M |
|
2652
International Flavors & Fragrances
IFF
$21.9B
| $6.08M | ﹤0.01% |
66,952
-396,517
| -86% | -$45.4M |
|
2653
Kodiak Sciences
KOD
$2.84B
| $6.07M | ﹤0.01% |
784,150
+291,767
| +59% | +$2.84M |
|
|
FAZE
2654
PUT
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $6.07M | ﹤0.01% |
+627,000
| New | +$8.33M |
|
2655
Evolus
EOLS
$501M
| $6.07M | ﹤0.01% |
753,788
+217,375
| +41% | +$2.3M |
|
|
SWET
2656
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
| $6.06M | ﹤0.01% |
614,000
-2,564
| -0.4% | -$25.3K |
|
2657
CALL
Arthur J. Gallagher & Co
AJG
$63.6B
| $6.04M | ﹤0.01% |
35,300
+16,200
| +85% | +$2.88M |
|
|
KYCH
2658
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
| $6.04M | ﹤0.01% |
605,896
| – | – |
|
2659
Acadia Pharmaceuticals
ACAD
$5.03B
| $6.03M | ﹤0.01% |
368,678
-485,599
| -57% | -$7.86M |
|
2660
CALL
Corning
GLW
$143B
| $6.03M | ﹤0.01% |
207,700
+5,600
| +3% | +$190K |
|
2661
Cytek Biosciences
CTKB
$546M
| $6.01M | ﹤0.01% |
408,459
-494,023
| -55% | -$6.42M |
|
2662
HEICO Corp
HEI
$51.4B
| $6.01M | ﹤0.01% |
41,751
+31,539
| +309% | +$4.73M |
|
|
LFAC
2663
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
| $6.01M | ﹤0.01% |
597,537
+7,167
| +1% | +$72K |
|
|
RCAC
2664
DELISTED
Revelstone Capital Acquisition Corp. Class A Common Stock
RCAC
| $6M | ﹤0.01% |
606,527
| – | – |
|
2665
CEMIG Preferred Shares
CIG
$6.01B
| $6M | ﹤0.01% |
3,863,196
-5,790
| -0.1% | -$9.97K |
|
2666
Douglas Dynamics
PLOW
$1.02B
| $5.99M | ﹤0.01% |
213,747
+177,380
| +488% | +$5.4M |
|
2667
Tanger
SKT
$4.52B
| $5.99M | ﹤0.01% |
437,666
+423,689
| +3,031% | +$6.58M |
|
2668
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $5.97M | ﹤0.01% |
+33,240
| New | +$6.62M |
|
2669
Sable Offshore Corp
SOC
$911M
| $5.95M | ﹤0.01% |
605,600
-1,786
| -0.3% | -$17.5K |
|
2670
Marqeta
MQ
$1.66B
| $5.94M | ﹤0.01% |
208,562
-564,705
| -73% | -$18.8M |
|
2671
Travel + Leisure Co
TNL
$4.7B
| $5.93M | ﹤0.01% |
173,919
-371,018
| -68% | -$15.7M |
|
2672
Oneok
OKE
$54.5B
| $5.93M | ﹤0.01% |
115,757
-409,014
| -78% | -$24.3M |
|
|
FISV
2673
Fiserv Inc
FISV
$27.9B
| $5.93M | ﹤0.01% |
63,373
-253,974
| -80% | -$25.9M |
|
|
GTPA
2674
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $5.92M | ﹤0.01% |
602,643
-20,691
| -3% | -$203K |
|
|
EBAC
2675
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $5.91M | ﹤0.01% |
596,572
| – | – |
|
Similar funds
Millennium Management's Q3 2022 Portfolio in Review
As of Q3 2022, Millennium Management held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $14.7B of net new capital in Q3 2022, opening 1,007 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Millennium Management's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Millennium Management added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Millennium Management's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Millennium Management fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Millennium Management's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Millennium Management opened 1,007 new positions and closed 906 in Q3 2022.
- Millennium Management's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.